Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus

Psoriasis (PsO) is a chronic, immune-mediated, inflammatory skin disease associated in most cases with pruritus. Chemokines seem to play a significant role in PsO pathogenesis. The aim of the study was to analyse serum concentrations of CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β, CCL5/RANTES, CCL17/TARC,...

Full description

Bibliographic Details
Main Authors: Dorota Purzycka-Bohdan, Bogusław Nedoszytko, Monika Zabłotna, Jolanta Gleń, Aneta Szczerkowska-Dobosz, Roman J. Nowicki
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/21/13330
_version_ 1797467919138947072
author Dorota Purzycka-Bohdan
Bogusław Nedoszytko
Monika Zabłotna
Jolanta Gleń
Aneta Szczerkowska-Dobosz
Roman J. Nowicki
author_facet Dorota Purzycka-Bohdan
Bogusław Nedoszytko
Monika Zabłotna
Jolanta Gleń
Aneta Szczerkowska-Dobosz
Roman J. Nowicki
author_sort Dorota Purzycka-Bohdan
collection DOAJ
description Psoriasis (PsO) is a chronic, immune-mediated, inflammatory skin disease associated in most cases with pruritus. Chemokines seem to play a significant role in PsO pathogenesis. The aim of the study was to analyse serum concentrations of CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β, CCL5/RANTES, CCL17/TARC, CCL18/PARC, CCL22/MDC and CXCL8/IL-8, and their correlation with PsO severity and pruritus intensity. The study included 60 PsO patients and 40 healthy volunteers. Serum concentrations of six (CCL2/MCP-1, CCL3/MIP-1α, CCL5/RANTES, CCL17/TARC, CCL18/PARC and CCL22/MDC) out of eight analysed chemokines were significantly elevated in PsO patients; however, they did not correlate with disease severity. The serum level of CCL5/RANTES was significantly higher in patients with the psoriasis area and severity index (PASI) ≥ 15 (<i>p</i> = 0.01). The serum concentration of CCL17/TARC correlated positively with pruritus assessed using the visual analogue scale (VAS) (R = 0.47; <i>p</i> = 0.05). The study indicated CCL17/TARC as a potential biomarker of pruritus intensity in PsO patients. Chemokines appear to be involved in the development of PsO systemic inflammation. Further detailed studies on the interactions between chemokines, proinflammatory cytokines and immune system cells in PsO are required to search for new targeted therapies.
first_indexed 2024-03-09T19:00:36Z
format Article
id doaj.art-6855673234f14cb18da54579ace30e22
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T19:00:36Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6855673234f14cb18da54579ace30e222023-11-24T05:06:11ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123211333010.3390/ijms232113330Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and PruritusDorota Purzycka-Bohdan0Bogusław Nedoszytko1Monika Zabłotna2Jolanta Gleń3Aneta Szczerkowska-Dobosz4Roman J. Nowicki5Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, PolandDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, PolandDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, PolandDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, PolandDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, PolandDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, PolandPsoriasis (PsO) is a chronic, immune-mediated, inflammatory skin disease associated in most cases with pruritus. Chemokines seem to play a significant role in PsO pathogenesis. The aim of the study was to analyse serum concentrations of CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β, CCL5/RANTES, CCL17/TARC, CCL18/PARC, CCL22/MDC and CXCL8/IL-8, and their correlation with PsO severity and pruritus intensity. The study included 60 PsO patients and 40 healthy volunteers. Serum concentrations of six (CCL2/MCP-1, CCL3/MIP-1α, CCL5/RANTES, CCL17/TARC, CCL18/PARC and CCL22/MDC) out of eight analysed chemokines were significantly elevated in PsO patients; however, they did not correlate with disease severity. The serum level of CCL5/RANTES was significantly higher in patients with the psoriasis area and severity index (PASI) ≥ 15 (<i>p</i> = 0.01). The serum concentration of CCL17/TARC correlated positively with pruritus assessed using the visual analogue scale (VAS) (R = 0.47; <i>p</i> = 0.05). The study indicated CCL17/TARC as a potential biomarker of pruritus intensity in PsO patients. Chemokines appear to be involved in the development of PsO systemic inflammation. Further detailed studies on the interactions between chemokines, proinflammatory cytokines and immune system cells in PsO are required to search for new targeted therapies.https://www.mdpi.com/1422-0067/23/21/13330chemokinespsoriasisdisease severitypruritus
spellingShingle Dorota Purzycka-Bohdan
Bogusław Nedoszytko
Monika Zabłotna
Jolanta Gleń
Aneta Szczerkowska-Dobosz
Roman J. Nowicki
Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
International Journal of Molecular Sciences
chemokines
psoriasis
disease severity
pruritus
title Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
title_full Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
title_fullStr Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
title_full_unstemmed Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
title_short Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
title_sort chemokine profile in psoriasis patients in correlation with disease severity and pruritus
topic chemokines
psoriasis
disease severity
pruritus
url https://www.mdpi.com/1422-0067/23/21/13330
work_keys_str_mv AT dorotapurzyckabohdan chemokineprofileinpsoriasispatientsincorrelationwithdiseaseseverityandpruritus
AT bogusławnedoszytko chemokineprofileinpsoriasispatientsincorrelationwithdiseaseseverityandpruritus
AT monikazabłotna chemokineprofileinpsoriasispatientsincorrelationwithdiseaseseverityandpruritus
AT jolantaglen chemokineprofileinpsoriasispatientsincorrelationwithdiseaseseverityandpruritus
AT anetaszczerkowskadobosz chemokineprofileinpsoriasispatientsincorrelationwithdiseaseseverityandpruritus
AT romanjnowicki chemokineprofileinpsoriasispatientsincorrelationwithdiseaseseverityandpruritus